Aptatek Biosciences is pioneering the development of portable disease management devices that detect small molecules otherwise only identifiable in a laboratory setting. The company's core product is a handheld, battery-powered, Bluetooth-enabled device that allows patients and healthcare providers to perform diagnostic tests at home or at the point of care. This innovative technology is based on DNA aptamer sequences, which offer high sensitivity and specificity in detecting biomarkers that traditional antibodies cannot identify. Aptatek primarily serves patients with chronic conditions requiring regular monitoring, such as Phenylketonuria (PKU), and aims to improve patient compliance, wellness, and overall quality of life. The company operates in the medical diagnostics market and follows a business model that includes direct sales to healthcare providers and partnerships with medical institutions. Revenue is generated through the sale of devices and recurring income from consumables and software services.

Keywords: portable diagnostics, small molecule detection, DNA aptamers, PKU management, Bluetooth-enabled, handheld device, patient compliance, chronic conditions, medical diagnostics, healthcare technology.